Annovis Bio Stock (NYSE: ANVS) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 208.000 / 231.354K |
Day Range | - - - |
52 Wk Range | 5.420 - 22.490 |
Market Cap | $149.864M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NYSE |
RSI | 66 |
Short Interest | 18.02% |
Days to Cover | 3.29 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Annovis Bio (NYSE: ANVS) through any online brokerage.
Other companies in Annovis Bio’s space includes: Syros Pharmaceuticals (NASDAQ:SYRS), Molecular Partners (NASDAQ:MOLN), bluebird bio (NASDAQ:BLUE), Vistagen Therapeutics (NASDAQ:VTGN) and Tevogen Bio Holdings (NASDAQ:TVGN).
The latest price target for Annovis Bio (NYSE: ANVS) was reported by HC Wainwright & Co. on Tuesday, April 2, 2024. The analyst firm set a price target for 30.00 expecting ANVS to rise to within 12 months (a possible 120.43% upside). 10 analyst firms have reported ratings in the last year.
The stock price for Annovis Bio (NYSE: ANVS) is $13.61 last updated April 25, 2024 at 7:54 PM EDT.
There are no upcoming dividends for Annovis Bio.
Annovis Bio’s Q1 earnings are confirmed for Thursday, May 9, 2024.
There is no upcoming split for Annovis Bio.
Annovis Bio is in the Health Care sector and Biotechnology industry. They are listed on the NYSE.